| 1 |
33758937 | High Levels of Thyroid Hormone Impair Regulatory T Cell Function Via Reduced PD-1 Expression. | 2021 Aug 18 |
7 |
| 2 |
33986285 | Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson's disease. | 2021 May 13 |
2 |
| 3 |
34061898 | TGF-β inhibition can overcome cancer primary resistance to PD-1 blockade: A mathematical model. | 2021 |
1 |
| 4 |
34073458 | Treg-Resistant Cytotoxic CD4+ T Cells Dictate T Helper Cells in Their Vicinity: TH17 Skewing and Modulation of Proliferation. | 2021 May 26 |
2 |
| 5 |
32319671 | Epitope competition and neutralizing antidrug antibodies: immune monitoring of antiprogrammed death-1 therapies and lessons learned from natalizumab. | 2020 Aug |
1 |
| 6 |
32840510 | Hybrid spherical nucleotide nanoparticles can enhance the synergistic anti-tumor effect of CTLA-4 and PD-1 blockades. | 2020 Sep 7 |
1 |
| 7 |
32902402 | The possible regulatory effect of the PD-1/PD-L1 signaling pathway on Tregs in ovarian cancer. | 2020 Jul |
3 |
| 8 |
32920330 | The association between monocytic myeloid-derived suppressor cells levels and the anti-tumor efficacy of anti-PD-1 therapy in NSCLC patients. | 2020 Dec |
4 |
| 9 |
33375291 | Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy. | 2020 Dec 26 |
3 |
| 10 |
24681107 | Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism. | 2014 May 15 |
1 |